Divi's Laboratories Limited (DIVISLAB) — Financial Results | 17 May 2025(3 announcements)

Divi's Laboratories reported consolidated revenue of ₹9,712 crores for FY2025, up 19% from ₹8,184 crores, with profit before tax rising 35% to ₹2,916 crores and net profit up 37% to ₹2,191 crores. The Board recommended a dividend of ₹30 per share (1500% payout) for FY2024-25, subject to shareholder approval at the August 11 AGM. Quarterly revenue reached ₹2,671 crores in Q3FY25, driven by strong API demand and a ₹48 crore forex gain. The company confirmed its greenfield project in Andhra Pradesh commenced commercial operations this quarter, supporting future growth. Auditor Price Waterhouse issued an unmodified opinion, validating financial accuracy and compliance.

Divi's Laboratories reported consolidated revenue of ₹9,712 crores for FY2025, up 19% from ₹8,184 crores, with profit before tax rising 35% to ₹2,916 crores and net profit up 37% to ₹2,191 crores. The Board recommended a dividend of ₹30 per share (1500% payout) for FY2024-25, subject to shareholder approval at the August 11 AGM. Quarterly revenue reached ₹2,671 crores in Q3FY25, driven by strong API demand and a ₹48 crore forex gain. The company confirmed its greenfield project in Andhra Pradesh commenced commercial operations this quarter, supporting future growth. Auditor Price Waterhouse issued an unmodified opinion, validating financial accuracy and compliance.

Divi's Laboratories reported a 69.9% YoY revenue increase to ₹87.22 crores for Q4 FY25, driven by strong performance in its API segment, while net profit rose 32% to ₹24.15 crores on higher margins and cost efficiencies.